XML 56 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
9 Months Ended
Sep. 30, 2012
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]  
Stock-Based Compensation
Stock Based Compensation:

The following table presents a summary of restricted stock and units activity during the period:
 
 
Shares
 
Weighted
Average
Grant Price
Balance, January 1, 2012
301,373

 
$
17.82

Granted
260,846

 
19.86

Vested
(58,292
)
 
23.43

Expired
0

 
0.00

Forfeited
(76,974
)
 
17.02

Outstanding, September 30, 2012
426,953

 
$
18.45


The following table presents a summary of stock option activity during the period:
 
Shares
 
Weighted
Average
Exercise
Price
Balance, January 1, 2012
15,800

 
$
1,393.65

Granted
0

 
0.00

Exercised
0

 
0.00

Expired
(973
)
 
1,519.35

Cancelled
(1,954
)
 
1,247.21

Outstanding, September 30, 2012
12,873

 
$
1,406.37

Exercisable, September 30, 2012
12,470

 
$
1,447.88



The following table presents the weighted average remaining contractual life and the aggregate intrinsic value for stock options as of the dates indicated: 
 
Stock Options
 
Outstanding
 
Exercisable
 
Weighted
Average Life
 
Intrinsic
Value
 
Weighted
Average Life
 
Intrinsic
Value
September 30, 2012
1.5 years
 
$
0

 
1.5 years
 
$
0

December 31, 2011
2.1 years
 
0

 
2.1 years
 
0



As of September 30, 2012, a total of 5,398,091 shares remained available for grant under Sterling’s 2003, 2007 and 2010 Long-Term Incentive Plans. The stock options granted under these plans have terms of four, six, eight and 10 years. Stock based compensation expense recognized during the periods presented was as follows:
 
Nine Months Ended September 30,
 
2012
 
2011
 
(in thousands)
Stock options
$
37

 
$
226

Restricted stock
2,719

 
2,723

Total
$
2,756

 
$
2,949



As of September 30, 2012, unrecognized equity compensation expense totaled $5.5 million as the underlying outstanding awards had not yet been earned. This amount will be recognized over a weighted average period of 2.2 years.